Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam F. Feyaerts has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inhibitory Activity of Essential Oils against Vibrio campbellii and Vibrio parahaemolyticus

    by Xiaoting Zheng, Adam F. Feyaerts, Patrick Van Dijck, Peter Bossier

    Vibriosis, caused by Vibrio strains, is an important bacterial disease and capable of causing significant high mortality in aquatic animals. Essential oils (EOs) have been considered as an alternative approach for the treatment of aquatic bacterial diseases. In this study, we evaluated the antibacterial activity of essential oils (n = 22) or essential oil components (EOCs, n = 12) against Vibrio strains belonging to the harveyi clade. It was verified by three different approaches, e.g., (i) a bacterial growth assay, comparing Vibrio growth with or without EO(C)s at various concentrations; (ii) a vapor-phase-mediated susceptibility assay, comparing the effect of EO(C)s on bacterial growth through the vapor phase; and (iii) a quorum sensing-inhibitory assay, based on specific inhibition of quorum sensing-regulated bioluminescence. The results showed that, in the bacterial growth assay, EOs of Melaleuca alternifolia and Litsea citrata at 0.0001%, Eucalyptus citriodora at 0.01% can inhibit the growth of Vibrio campbellii BB120. These EOs can also prevent the growth of V. parahaemolyticus strains but need to be present at a higher concentration (0.1%). Moreover, in the vapor-phase-mediated susceptibility assay, EOs of M. alternifolia, L. citrata and E. citriodora can inhibit the growth of V. campbellii BB120 through their vapor phase. However, V. parahaemolyticus strains (CAIM170, LMG2850 and MO904) cannot be inhibited by these EOs. Additionally, in the quorum sensing-inhibitory assay, EOs of Mentha pulegium, Cuminum cyminum, Zingiber officinalis, and E. citriodora, all at 0.001%, have quorum sensing-inhibitory activity in V. campbellii BB120. Taken together, our study provides substantial evidence that usage of the major components, individually or in combination, of the tested commercial EOs (extracted from M. alternifolia, L. citrata, and E. citriodora) could be a promising approach to control V. campbellii BB120.


  • Open Access

    Striking essential oil: tapping into a largely unexplored source for drug discovery

    by Adam F. Feyaerts, Walter Luyten, Patrick Van Dijck

    Essential oils (EOs) have been used therapeutically for centuries. In recent decades, randomized controlled (clinical) trials have supported efficacy in specific therapeutic indications for a few of them. Some EOs, their components or derivatives thereof have been approved as drugs. Nevertheless, they are still considered products that are mainly used in complementary and alternative medicine. EO components occupy a special niche in chemical space, that offers unique opportunities based on their unusual physicochemical properties, because they are typically volatile and hydrophobic. Here we evaluate selected physicochemical parameters, used in conventional drug discovery, of EO components present in a range of commercially available EOs. We show that, contrary to generally held belief, most EO components meet current-day requirements of medicinal chemistry for good drug candidates. Moreover, they also offer attractive opportunities for lead optimization or even fragment-based drug discovery. Because their therapeutic potential is still under-scrutinized, we propose that this be explored more vigorously with present-day methods.


  • Open Access

    Essential oils and their components are a class of antifungals with potent vapour-phase-mediated anti-Candida activity

    by Adam F. Feyaerts, Lotte Mathé, Walter Luyten, Stijn De Graeve, Katrien Van Dyck, Lize Broekx, Patrick Van Dijck

    Multi-resistant microorganisms continue to challenge medicine and fuel the search for new antimicrobials. Here we show that essential oils and their components are a promising class of antifungals that can have specific anti-Candida activity via their vapour-phase. We quantify the vapour-phase-mediated antimicrobial activity (VMAA) of 175 essential oils and 37 essential oil components, representing more than a 1,000 unique molecules, against C. albicans and C. glabrata in a novel vapour-phase-mediated susceptibility assay. Approximately half of the tested essential oils and their components show growth-inhibitory VMAA. Moreover, an average greater activity was observed against the intrinsically more resistant C. glabrata, with essential oil component citronellal having a highly significant differential VMAA. In contrast, representatives of each class of antifungals currently used in clinical practice showed no VMAA. The vapour-phase-mediated susceptibility assay presented here thus allows for the simple detection of VMAA and can advance the search for novel (applications of existing) antimicrobials. This study represents the first comprehensive characterisation of essential oils and their components as a unique class of antifungals with antimicrobial properties that differentiate them from existing antifungal classes.


  • Assay and recommendations for the detection of vapour‐phase‐mediated antimicrobial activities

    by Adam F. Feyaerts, Lotte Mathé, Walter Luyten, Hélène Tournu, Katrien Van Dyck, Lize Broekx, Patrick Van Dijck

    Antimicrobial activity assays can be carried out in aqueous solutions using multi‐well plates. However, some bioactive compounds are volatile and can cause effects at a distance. To detect such vapour‐phase‐mediated antimicrobial activity, we introduce the vapour‐phase‐mediated patch assay, a simple bioassay that uses standard microtitre plates. As a proof‐of‐principle, we use the vapour‐phase‐mediated patch assay to test a small but chemically diverse set of selected essential oils with known antifungal activities i.e. Origanum compactum, Artemisia dracunculus, Cinnamomum camphora ct linalool, Cinnamomum cassia and Melissa officinalis, as well as their corresponding major components carvacrol, estragole, linalool, trans‐cinnamaldehyde and citral, against two pathogenic Candida species. As all but one of the tested essential oils i.e. Artemisia dracunculus and its corresponding component estragole, showed vapour‐phase‐mediated antimicrobial activity, we conclude that it is a rather common characteristic of essential oils and their components, that should always be taken into consideration. Additionally, we provide suggestions to prevent false positive results due to possible vapour‐phase‐mediated antimicrobial activities in bioactivity tests.